Genius Sports Announces Addition to Russell 3000 ® Index
LONDON & NEW YORK--(BUSINESS WIRE)--Genius Sports Limited ('Genius Sports') (NYSE:GENI) has been added as a member of the broad-market Russell 3000 ® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution.
The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000 ® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 ® Index or small-cap Russell 2000 ® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
'Inclusion in the Russell 3000 ® Index marks an important milestone in Genius Sports' journey as a public company,' said Mark Locke, CEO of Genius Sports. 'This recognition enhances our visibility and broadens our reach with institutional investors as we continue to execute on our strategic plan.'
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider.
For more information on the Russell 3000 ® Index and the Russell indexes reconstitution, go to the 'Russell Reconstitution' section on the FTSE Russell website.
About Genius Sports
Genius Sports is the official data, technology and broadcast partner that powers the global sports, betting and media ecosystem. Our technology is used in over 150 countries worldwide, creating highly immersive products that enrich fan experiences across the entire sports industry.
We are the trusted partner to over 700 sports organizations, including many of the world's largest leagues, teams, sportsbooks, brands and broadcasters, such as the NFL, English Premier League, NCAA, DraftKings, FanDuel, bet365, Coca-Cola, EA Sports, CBS, NBC and ESPN.
Genius Sports is uniquely positioned through AI, computer vision and big data to power the future of sports fan experiences. From delivering augmented broadcasts and enhanced highlights, to automated officiating tools, immersive betting solutions and personalized marketing activations, we connect the entire sports value chain from the rights holder all the way through to the fan.
About FTSE Russell, an LSEG Business
FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering.
FTSE Russell is wholly owned by London Stock Exchange Group.
For more information, visit FTSE Russell.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNBC
17 minutes ago
- CNBC
Investors are on S&P 500 record watch. Here's what chart experts think
The S & P 500 is inching closer to a new all-time high, but chart experts are wondering if the rally is broad enough for more than a head fake. The broad index finished Tuesday's session less than 1% below its record high. If the S & P 500 topped that threshold, it would mark the first fresh all-time high hit for the benchmark since February, before the market whipsawed in the aftermath of President Donald Trump's tariff policy rollout. Now, market technicians are questioning whether the market's upswing can include enough stocks to successfully trade at all-time highs over a longer-term period. Otherwise, they say the S & P 500 may still notch a new record in the coming days, but the climb to uncharted territory would likely be short lived. "We've been arguing, really even since May, that there's enough market cap working to push the S & P 500 to a new all-time high," said Ari Wald, head of technical analysis at Oppenheimer. But, "there's a very fine line between a top and a breakout, and we haven't yet seen the conditions that would suggest that this breakout is sustainable." .SPX ALL mountain S & P 500 Wald pointed out that only 44% of Russell 3000 stocks traded above their 200-day moving averages, meaning less than half of members are considered to be in an uptrend. That raises questions about sustainability for the market, especially given that the S & P 500 sits within striking distance of a new record. In other words, he said that soldiers have to support generals to avoid a false breakout. On the other hand, Wald has also been watching the Russell 2000 , which he described as "pushing up" against its 200-day moving average. Positive momentum in these smaller-cap stocks can bode well for the broader market as the S & P 500 nears records, Wald said. "As go small caps, so goes the cycle," Wald said. "If small caps can start to break higher here, that would support broader participation and a continuation of the cycle." Other technicians have similar qualms about market leadership. Andrew Thrasher, founder of Thrasher Analytics, said some stocks haven't dug themselves out of the hole in the same way the S & P 500 has. "It's kind of a mixed bag," Thrasher said. "We are seeing some positives, but we really want to see breadth expand out more if we get to those highs." A 'recharged' market? In the short term, technicians agree that the S & P 500 should at least have enough momentum to touch all-time highs over the next several days. But for John Kolovos, head of technical strategy at Macro Risk Advisors, the remaining question is if the market has "recharged" enough to power a sustained move above current records. So far, Kolovos said he thinks the answer is yes. He said that the market tends to consolidate before hitting all-time highs, as was seen with the S & P 500 largely trading sideways in recent weeks. "If anything, the market has been going through a bit of a stealth correction over the past month," Kolovos said. Kolovos said a rollover in gold can help ignite animal spirits in the stock market. Down the road, he said outperformance in small caps and any signs of market breadth expanding can push investors to take on more market risk. Additionally, he said the Federal Reserve cutting interest rates would also boost trader sentiment. Beyond technology, Kolovos said the financial and industrial sectors are also doing well right now. These three sectors should be able to help propel the broader S & P 500 higher, he added. Looking ahead, Oppenheimer's Wald said market participants should stay exposed to the large-cap growth names that have shown strength so far in this cycle. That's evidenced by the performance of the Nasdaq 100 , which finished Tuesday's session at a record closing level.
Business Wire
39 minutes ago
- Business Wire
Simplify Healthcare and Atento Partner to Transform Member Experience Through Business Transformation Outsourcing (BTO)
AURORA, Ill.--(BUSINESS WIRE)-- Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, today announced a strategic partnership with Atento, a global leader in customer experience (CX) and Business Transformation Outsourcing (BTO). This collaboration introduces a co-developed, pilot-first CX program — powered by Simplify Healthcare's Xperience1™ platform — designed to help U.S. healthcare payers enhance member and provider experience, increase efficiency, and drive operational transformation without requiring upfront capital investment. This joint offering blends Simplify Healthcare's Xperience1™ platform with Atento's 'Technology with a Human Touch' philosophy and proven CX delivery capabilities. Together, the solution enables payers to improve member satisfaction (CSAT/NPS), reduce average call handle time, shorten training cycles, and deliver consistent, humanized experiences —quickly and at scale. 'This is a unique opportunity for payers to accelerate transformation without disruption,' said Ashish Desi, EVP and GM, Xperience1™ at Simplify Healthcare. 'Together, we're helping the industry leverage proven AI capabilities to pivot from complexity to clarity—with measurable impact on operations and the member experience.' Built on a no-CAPEX model, the solution enables health plans to test and scale CX transformation through a low-risk pilot approach. Key benefits include: Up to 50% reduction in average call handle time 100% elimination of post-call documentation Up to 50% reduction in agent training time Improved first-call resolution and member satisfaction No capital expenditure to get started This partnership with Simplify Healthcare is a powerful step forward in our commitment to Business Transformation Outsourcing," said Jim Carney, VP of Healthcare Sales, Atento. "We're giving payers a smarter path to CX modernization—built to deliver real outcomes without CAPEX, long timelines, or complexity. That's BTO in action.' Payers interested in launching a pilot with Atento and Simplify Healthcare can learn more at About Simplify Healthcare Simplify Healthcare enables Payers to achieve growth and cost efficiencies with its industry-leading platform, people, and processes. Established in 2008, Simplify Healthcare has taken on some of the toughest challenges facing payers by simplifying payer operations, connecting their front, middle, and back office with a payer-focused platform-centric approach. For more information, please visit Follow us on LinkedIn, YouTube, X, and Instagram. About Atento Atento is the largest provider of customer relationship management and business process outsourcing ('CRM BTO') services in Latin America. Atento is also one of the leading providers of nearshoring CRM BTO services for companies operating in the United States. Since 1999, the company has developed its business model in 17 countries, employing approximately 110,000 people. Serving more than 400 customers, Atento offers a wide range of CRM BTO services across multiple channels. The majority of Atento's clients are leading multinational companies in the telecommunications, banking and financial services, healthcare, retail, and government sectors. In recent years, the company has been recognized for its excellence by several industry analysts globally, including Everest, Gartner, Frost & Sullivan, and ISG. Forbes recognized Atento as one of the 100 best companies to work for in Spain in 2023, while Great Place to Work® has continuously ranked us as one of the 25 best companies to work for globally. We have also been recognized as the 1st company in the sector globally to achieve the ISO 56002 Innovation Management Certification, which we have maintained for four consecutive years. For more information, visit
Yahoo
41 minutes ago
- Yahoo
Greg Peton to Lead Pivot Bio's Coastal Region, Helping More Farmers Optimize Crop Nutrition
COURTLAND, Minn., June 25, 2025 /PRNewswire/ -- Pivot Bio, one of the world's most innovative agtech companies, has named Greg Peton as regional sales leader for its coastal region. In this role, Peton will lead sales efforts across a broad territory stretching from Texas through the Carolinas and into the Northeast, including New York, Pennsylvania and the Delmarva region, supporting farmers and retail partners with Pivot Bio's award-winning, patented crop nutrition technologies. These include the company's third-generation nitrogen product for corn, PROVEN® G3, and its new cotton solution, CERT-N®. These tools have been adopted across more than 15 million acres over the past several seasons, reflecting strong farmer demand and field performance. "Greg knows what it takes to help farmers succeed, and he understands the realities of crop nutrition from the ground up," said Chris Turner, chief commercial officer at Pivot Bio. "He's a strong leader with deep roots in agriculture, and we're lucky to have him leading the charge in a critical part of the country." Peton brings decades of experience in agricultural sales and leadership, with a background that spans seed, crop protection and agronomy services. He joined Pivot Bio in 2020 and most recently served as a national account manager, during which time he built trusted relationships with some of the largest growers in the U.S. "Greg brings a steady hand and real operational strength to the field," said Daryl Allen, vice president of sales at Pivot Bio. "He understands how to navigate complex operations, align teams, and deliver value for both farmers and our retail partners." Prior to Pivot Bio, Peton held senior roles at DuPont Pioneer, Rizobacter and United Farmers Cooperative, where he served as chief sales and marketing officer. He grew up on a diversified grain, dairy and livestock farm in northwest Iowa. About Pivot BioPivot Bio, one of the world's leading innovative agtech companies, delivers to farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow the food the world needs in the face of increasing volatility. Currently available in North America and soon in Brazil, the company's products are a breakthrough innovation and one of the agriculture industry's most promising solutions. Pivot Bio has been recognized three times by Time magazine on its annual list of best inventions, by Fast Company on its World Changing Ideas and World's 50 Most Innovative Companies lists, by CNBC on its Disruptor 50 list of private companies, by Fortune on its Impact 20 list of startups driving social good and by MIT Tech Review as one of 15 climate tech companies to watch. For more information, visit View original content to download multimedia: SOURCE Pivot Bio, Inc Sign in to access your portfolio
